Sopharma AD-Sofia (FRA:3JR) Dividend Yield %: 0.00% (As of Jul. 05, 2026)


FRA:3JR Sopharma AD-Sofia FRA:3JR
65 GF Score
Price €1.84
GF Value €3.02
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia Dividend Yield %?

Sopharma AD-Sofia FRA:3JR +6.36% 65 Dividend Yield % is 0.00% as of Jul. 05, 2026. GuruFocus rates FRA:3JR with a GF Score™ of 65/100 and a GF Value™ of €3.02 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 69 Medical Distribution companies, Sopharma AD-Sofia ranks better than 72.46% on this metric.

As of today (2026-07-05), the Trailing Annual Dividend Yield of Sopharma AD-Sofia is 0.00%.

The historical rank and industry rank for Sopharma AD-Sofia's Dividend Yield % or its related term are showing as below:

During the past 13 years, the highest Dividend Yield of Sopharma AD-Sofia was 13.36%. The lowest was 0.44%. And the median was 1.29%.

FRA:3JR's Dividend Yield % is not ranked *
in the Medical Distribution industry.
Industry Median: 2.88
* Ranked among companies with meaningful Dividend Yield % only.

Sopharma AD-Sofia's Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of Sopharma AD-Sofia was 2.21. The lowest was 0.07. And the median was 0.37.

As of today (2026-07-05), the Forward Dividend Yield % of Sopharma AD-Sofia is 5.65%.

Sopharma AD-Sofia's Dividends per Share for the three months ended in Mar. 2026 was €0.00.

During the past 12 months, Sopharma AD-Sofia's average Dividends Per Share Growth Rate was 2.40% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sopharma AD-Sofia was 138.90% per year. The lowest was -11.40% per year. And the median was 1.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Sopharma AD-Sofia  (FRA:3JR) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Sopharma AD-Sofia Dividend Yield % Related Terms


Sopharma AD-Sofia Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Sopharma AD-Sofia's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia Dividend Yield % Chart

Sopharma AD-Sofia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sopharma AD-Sofia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:3JR vs MCK, CAH, COR: Dividend Yield % Comparison

For the Medical Distribution subindustry, Sopharma AD-Sofia's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia Dividend Yield % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Dividend Yield % falls into.


FRA:3JR
65GF Score
Sopharma AD-Sofia FRA:3JR
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma AD-Sofia Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Sopharma AD-Sofia (FRA:3JR) has a Dividend Yield % of 0.00% as of Jul. 05, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Sopharma AD-Sofia and its competitors. Over the past decade, Sopharma AD-Sofia's Dividend Yield % has ranged from 0.44 to 13.36. According to the industry distribution chart, Sopharma AD-Sofia ranks #19 out of 69 companies in the Medical Distribution industry, placing it in the top 27.5%.
Is Sopharma AD-Sofia's Dividend Yield % too high?
Sopharma AD-Sofia's current Dividend Yield % is 0.00%. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 13.36. Based on the distribution chart, Sopharma AD-Sofia ranks #19 out of 69 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Sopharma AD-Sofia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's Dividend Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sopharma AD-Sofia ranks #19 out of 69 companies for Dividend Yield %. This puts Sopharma AD-Sofia in the upper half of its industry. The industry median Dividend Yield % is 2.88. Historically, Sopharma AD-Sofia's own Dividend Yield % has ranged from 0.44 to 13.36 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Distribution company?
The median Dividend Yield % among Medical Distribution companies is 2.88, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Sopharma AD-Sofia and its competitors. For the Medical Distribution industry, the median Dividend Yield % is 2.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma AD-Sofia's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (FRA:3JR) is currently considered Possible Value Trap. The stock's GF Value™ is €3.02, compared to a current price of €1.84 — trading 39.1% below its estimated fair value. The current Dividend Yield % is 0.00%. Sopharma AD-Sofia's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Sopharma AD-Sofia (FRA:3JR), the current Dividend Yield % is 0.00% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma AD-Sofia (FRA:3JR) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued. The current stock price of €1.84 is trading 39.1% below its estimated GF Value™ of €3.02. GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.

Key valuation signals for FRA:3JR:

  • Dividend Yield %: 0.00%
  • GF Value™: €3.02 vs. price of €1.84 (39.1% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the FRA:3JR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma AD-Sofia Business Description

Other Exchanges SPH:PolandSFA:Bulgaria
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
65GF Score

Get the complete analysis for FRA:3JR

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.84
Price
€3.02
GF Value